Circumventing recombination events encountered with production of a clinical-grade adenoviral vector with a double-expression cassette

Molecular Pharmacology

Volumn 70, Issue 5, 2006, Pages 1488-1493

  Belousova, Natalya ^a,d   Harris, Raymond ^c   Zinn, Kurt ^b   Rhodes Selser, Mary Ann ^c   Kotov, Alexander ^a   Kotova, Olga ^a   Wang, Minghui ^a   Aurigemma, Rosemarie ^c   Zhu, Zeng B ^a   Curiel, David T ^a,b   Alvarez, Ronald D ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c SAIC FREDERICK INC   (United States)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; POLYADENYLIC ACID; SOMATOSTATIN RECEPTOR 2; THYMIDINE KINASE; VIRUS ENZYME;

ADENOVIRUS VECTOR; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; EXPRESSION VECTOR; GENE CASSETTE; GENE DELETION; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENETIC RECOMBINATION; GENETIC TRANSDUCTION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; TRANSGENE;

ADENOVIRIDAE; BASE SEQUENCE; CELLS, CULTURED; GENETIC ENGINEERING; GENETIC VECTORS; GENOME, VIRAL; HUMANS; PEPTIDES; RECOMBINATION, GENETIC; REPRODUCIBILITY OF RESULTS; SEQUENCE DELETION; SEQUENCE HOMOLOGY; TRANSGENES;

EID: 33751174107     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.106.025619     Document Type: Article

References (21)

1. Antony PA, Paulos CM, Ahmadzadeh M, Akpinarli A, Palmer DC, Sato N, Kaiser A, Heinrichs C, Klebanoff CA, Tagaya Y, and Restifo NP (2006) Interleukin-2-dependent mechanisms of tolerance and immunity in vivo. J Immunol 176:5255-5266.
2. Belousova N, Korokhov N, Krendelshchikova V, Simonenko V, Mikheeva G, Triozzi PL, Aldrich WA, Banerjee PT, Gillies SD, Curiel DT, et al. (2003) Genetically targeted adenovirus vector directed to CD40-expressing cells. J Virol 77:11367-11377.
3. Buchsbaum DJ (2004) Imaging and therapy of tumors induced to express somatostatin receptor by gene transfer using radiolabeled peptides and single chain antibody constructs. Semin Nucl Med 34:32-46.
4. Cannistra SA, Ottensmeier C, Niloff J, Orta B, and DiCarlo J (1995) Expression and function of beta 1 and alpha v beta 3 integrins in ovarian cancer. Gynecol Oncol 58:216-225.
5. Cooper CR, Chay CH, and Pienta KJ (2002) The role of alpha (v) beta (3) in prostate cancer progression. Neoplasia (NY) 4:191-194.
6. Dmitriev I, Krasnykh V, Miller CR, Wang M, Kashentseva E, Mikheeva G, Belousova N, and Curiel DT (1998) An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism. J Virol 72:9706-9713.
7. Driesse MJ, Vincent AJ, Sillevis Smitt PA, M.Kros J, Hoogerbrugge PM, Avezaat CJ, Valerio D, and Bout A (1998) Intracerebral injection of adenovirus harboring the HSVtk gene combined with ganciclovir administration: toxicity study in nonhuman primates. Gene Ther 5:1122-1129.
8. Gaken J, Jiang J, Daniel K, van Berkel E, Hughes C, Kuiper M, Darling D, Tavassoli M, Galea-Lauri J, Ford K, et al. (2000) Fusagene vectors: a novel strategy for the expression of multiple genes from a single cistron. Gene Ther 7:1979-1985.
9. Hemminki A, Belousova N, Zinn KR, Liu B, Wang M, Chaudhuri TR, Rogers BE, Buchsbaum DJ, Siegal GP, Barnes MN, et al. (2001) An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expression. Mol Ther 4:223-231.
10. Hemminki A, Zinn KR, Liu B, Chaudhuri TR, Desmond RA, Rogers BE, Barnes MN, Alvarez RD, and Curiel DT (2002) In vivo molecular chemotherapy and noninvasive imaging with an infectivity-enhanced adenovirus. J Natl Cancer Inst 94:741-749.
11. Jozkowicz A and Dulak J (2005) Helper-dependent adenoviral vectors in experimental gene therapy. Acta Biochim Pol 52:589-599.
12. Kwong YL, Chen SH, Kosai K, Finegold M, and Woo SL (1997) Combination therapy with suicide and cytokine genes for hepatic metastases of lung cancer. Chest 112:1332-1337.
13. Li D, Duan L, Freimuth P, and O'Malley BW Jr (1999a) Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer. Clin Cancer Res 5:4175-4181.
14. Li Y, Pong RC, Bergelson JM, Hall MC, Sagalowsky AI, Tseng CP, Wang Z, and Hsieh JT (1999b) Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy. Cancer Res 59:325-330.
15. Mortarini R and Anichini A (1993) From adhesion to signalling: roles of integrins in the biology of human melanoma. Melanoma Res 3:87-97.
16. Ray P, De A, Min JJ, Tsien RY, and Gambhir SS (2004) Imaging tri-fusion multimodality reporter gene expression in living subjects. Cancer Res 64:1323-1330.
17. Schiedner G, Hertel S, and Kochanek S (2000) Efficient transformation of primary human amniocytes by E1 functions of Ad5: generation of new cell lines for adenoviral vector production. Hum Gene Ther 11:2105-2116.
18. Wang Y, Iyer M, Annala AJ, Chappell S, Mauro V, and Gambhir SS (2005) Noninvasive monitoring of target gene expression by imaging reporter gene expression in living animals using improved bicistronic vectors. J Nucl Med 46:667-674.
19. Wen XY, Mandelbaum S, Li ZH, Hitt M, Graham FL, Hawley TS, Hawley RG, and Stewart AK (2001) Tricistronic viral vectors co-expressing interleukin-12 (1L-12) and CD80 (B7-1) for the immunotherapy of cancer: preclinical studies in myeloma. Cancer Gene Ther 8:361-370.
20. Westlin WF (2001) Integrins as targets of angiogenesis inhibition. Cancer J 7 (Suppl 3):S139-S143.
21. Yaghoubi SS, Wu L, Liang Q, Toyokuni T, Barrio JR, Namavari M, Satyamurthy N, Phelps ME, Herschman HR, and Gambhir SS (2001) Direct correlation between positron emission tomographic images of two reporter genes delivered by two distinct adenoviral vectors. Gene Ther 8:1072-1080.